Skip to content

Clinical trials

Phase 2 Giant Cell Arteritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Giant Cell Arteritis Phase: Phase 2 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20181
20191
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC1
Kiniksa Pharmaceuticals, Ltd.1
Matthew J Koster1
NYU Langone Health1
National Institute of Allergy and Infectious Diseases (NIAID)1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Giant Cell Arteritis7
Granulomatosis with Polyangiitis2
Takayasu Arteritis2
Vasculitis2
Arteritis1
Arthritis, Juvenile1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Churg-Strauss Syndrome1
Dermatomyositis1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.